SRx Health Solutions Announces Series B Preferred Private Placement

SRx Health Solutions ( (SRXH) ) has provided an update.

On March 16, 2026, SRx Health Solutions entered into a Securities Purchase Agreement with accredited investors for a private placement of up to 10,000 shares of Series B convertible preferred stock and accompanying warrants, for potential gross proceeds of up to $8 million in one or more closings. At the initial closing on the same date, the company raised approximately $4.53 million in cash by issuing 5,660 Series B preferred shares and 22,237,666 warrants, with the warrants and conversion features set at an initial price of $0.3182 per share, subject to various adjustments after shareholder approval.

The newly designated Series B Preferred Stock carries a $1,000 stated value per share, ranks senior to common stock and pari passu with Series A preferred, offers as-converted dividends, and provides multiple conversion and redemption mechanisms tied to market prices and triggering events. The structure includes strict covenants limiting additional indebtedness, dividends, new preferred issuances, and certain fundamental transactions, and requires substantial share reservation and a registration rights agreement to facilitate resale, signaling both a near-term capital infusion and tighter contractual constraints that may affect equity holders and future financing flexibility.

The most recent analyst rating on (SRXH) stock is a Hold with a $0.14 price target. To see the full list of analyst forecasts on SRx Health Solutions stock, see the SRXH Stock Forecast page.

Spark’s Take on SRXH Stock

According to Spark, TipRanks’ AI Analyst, SRXH is a Underperform.

The score is primarily constrained by weak financial performance (large losses, high leverage, and current cash burn). Technicals also point to a sustained downtrend (price below key moving averages and negative MACD). Valuation looks optically low on P/E but is not compelling given the stated earnings/cash-flow weakness, while corporate events add additional risk due to financing/dilution and listing compliance issues.

To see Spark’s full report on SRXH stock, click here.

More about SRx Health Solutions

SRx Health Solutions, Inc., a Delaware corporation, operates in the healthcare sector and is listed on the NYSE American exchange. The company’s capital structure includes common stock and multiple series of convertible preferred stock, which it uses to raise financing from accredited investors through private placement transactions.

Average Trading Volume: 28,023,896

Technical Sentiment Signal: Strong Sell

Current Market Cap: $45.18M

For detailed information about SRXH stock, go to TipRanks’ Stock Analysis page.